IRWD
Ironwood Pharmaceuticals Inc
3.60$
-3.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 48.4% | 49.5% | 47.4% | 45.0% | 45.9% | 52.0% | 49.1% | 55.9% | 69.1% | 69.1% | 76.5% | 69.9% | |
| 21.0% | 19.6% | 27.7% | 26.7% | 22.6% | 25.2% | 33.2% | 27.1% | 35.5% | 54.3% | 50.7% | 27.8% | |
| 21.0% | 19.6% | 27.7% | 26.7% | 22.6% | 25.2% | 33.2% | 27.1% | 35.5% | 54.3% | 50.7% | 27.8% | |
| 23.8% | 27.4% | 16.4% | 14.7% | 19.6% | 23.3% | 12.2% | 25.1% | 30.4% | 11.8% | 24.4% | 39.5% | |
| 0.2% | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 0.7% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.7% | 0.6% | 0.5% | 0.4% | 0.6% | |
| 162.1% | 173.5% | 175.3% | 181.3% | 179.9% | 185.9% | 202.1% | 189.9% | 166.7% | 166.0% | 150.0% | 156.8% | |
| 53.5% | 58.6% | 57.5% | 11.5% | 12.7% | 11.1% | 14.7% | 67.8% | 61.2% | 61.0% | 54.4% | 11.5% | |
| 38.6% | 43.0% | 46.2% | 0.8% | 0.8% | 0.9% | 1.0% | 59.1% | 51.2% | 51.1% | 46.7% | 1.2% | |
| 0.9% | 1.7% | 1.4% | 0.8% | 0.8% | 0.6% | 1.8% | 0.4% | 0.4% | 0.7% | 0.7% | 0.3% | |
| 99.8% | 105.8% | 107.9% | 157.6% | 153.7% | 166.4% | 178.5% | 112.3% | 97.2% | 97.0% | 88.6% | 135.0% | |
| -61.7% | -73.5% | -75.3% | -81.3% | -79.9% | -85.9% | -102.1% | -89.9% | -66.7% | -66.0% | -50.0% | -56.8% | |
| -323.9% | -360.6% | -388.0% | -430.6% | -436.4% | -483.8% | -530.3% | -499.1% | -422.0% | -421.7% | -375.8% | -554.7% | |
| 35.7% | 33.1% | 35.9% | 40.2% | 41.1% | 45.7% | 49.2% | 47.2% | 44.9% | 44.8% | 38.4% | 58.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.